UNC-Chapel Hill announced a partnership this week with pharmaceutical giant GlaxoSmithKline to work on a cure for AIDS.
Scientists say what once was a lofty goal is now more realistic, thanks in part to UNC's already-extensive AIDS research.
GSK and UNC will create a company called Qura Therapeutics to oversee more research at UNC laboratories, with an eye on producing a cure within the next 30 years.
Host Frank Stasio talks with Triangle Business Journal reporter Jason deBruyn about the details of the partnership.